NCT00014378View on ClinicalTrials.gov

Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

Chinese Herb Huanglian (Coptis chinesis)

Patients will receive capsules of the powdered extract of the huanglian root, which will take by mouth 4 times a day (qid).

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00014378 - Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter